Regulatory/FDA

Coalition Supports FDA Revision of Patient Information Requirements

In our informative slideshow, John Kamp, executive director of the Coalition, discusses steps the FDA should buy online viagra take to improve the information required to be given patients when prescribed a drug. The topics covered in the slideshow include

  • Who We Are, Mission & Passions
  • FDA Correctly Seizing the Moment
  • Bold Action Needed
  • What Needs to Happen
  • How Can We Help?

View the slideshow

We invite comments!levitra sex pill

Categories

Recent Posts

Tags

ad tax Advertising Coalition CDER CMS coalition for healthcare communication conflict of interest Congress COVID-19 data privacy DDMAC drug prices in DTC ads drug pricing DTC DTC advertising DTC advertising FDA FDA Commissioner FDA Draft Guidance FDA enforcement FDA social media free speech gifts to physicians HHS John Kamp Jon Bigelow kamp Kate Rawson legislation litigation marketing off-label off-label communication omission of risk OPDP OPDP enforcement PhRMA regulation Risk Information rx data Scott Gottlieb social media sunshine act Untitled Letter Warning Letter Wayne Pines